Charmacy Pharmaceutical Co., Ltd. Class H (HK:2289) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Charmacy Pharmaceutical Co., Ltd. has announced successful passage of all resolutions at their Annual General Meeting (AGM) held on May 20, 2024, including the approval of the Board’s reports and financial statements, the re-election of directors and supervisors, and the declaration of a final dividend for 2023. The approved resolutions also include the re-appointment of SHINEWING Certified Public Accountants as auditors and the authorization of a comprehensive revolving credit line not exceeding RMB 2.4 billion.
For further insights into HK:2289 stock, check out TipRanks’ Stock Analysis page.